Roivant Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ROIV and other ETFs, options, and stocks.

About ROIV

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. 

CEO
Matthew Gline
CEOMatthew Gline
Employees
908
Employees908
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2021
Founded2021
Employees
908
Employees908

ROIV Key Statistics

Market cap
7.85B
Market cap7.85B
Price-Earnings ratio
-75.98
Price-Earnings ratio-75.98
Dividend yield
—
Dividend yield—
Average volume
6.04M
Average volume6.04M
High today
$11.18
High today$11.18
Low today
$10.88
Low today$10.88
Open price
$10.89
Open price$10.89
Volume
8.02M
Volume8.02M
52 Week high
$13.06
52 Week high$13.06
52 Week low
$8.73
52 Week low$8.73

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.